Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults
Sponsor: Enanta Pharmaceuticals, Inc
Summary
This study is a randomized, double-blind, sponsor-open, placebo-controlled study. It will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of orally administered single and multiple doses of EDP-978 in healthy adult subjects.
Official title: A Randomized, Double-Blind, Sponsor-Open, Placebo-Controlled, First-In-Human, Phase 1 Study of Orally Administered EDP-978 to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses, Multiple Ascending Doses, and the Effect of Food on EDP-978 Pharmacokinetics in Healthy Adult Participants
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
98
Start Date
2026-04-01
Completion Date
2026-11
Last Updated
2026-04-21
Healthy Volunteers
Yes
Interventions
EDP-978
Oral administration
Placebo
Placebo to match EDP-978, oral administration
Locations (1)
ICON Early Phase
San Antonio, Texas, United States